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Oral controlled release systems 
Historically, oral drug administration has been the 
predominant route for drug delivery. It is known to be 
the most popular route of drug administration due to the 
fact the gastrointestinal physiology offers more 
flexibility in dosage form design than most other routes 
(Chen et al. 2010, Gupta and Robinson 1992, Maderuelo 
et al.  2011, Tongwen and Binglin 1998). A major 
challenge for the pharmaceutical industry in drug 
development is to produce safe and efficient drugs, 
therefore properties of drugs and the way in which they 
are delivered must be optimised. 
A controlled release drug delivery system delivers the 
drug locally or systemically at a predetermined rate for a 
specified period of time (Chen et al. 2010, Nair et al. 
2010, Rajput et al. 2010). The goal of such systems is to 
provide desirable delivery profiles that can achieve 
therapeutic plasma levels (Chen et al. 2010, Grundy and 
Foster 1996, Lordi 1986). Drug release is dependent on 
polymer properties, thus the application of these 
properties can produce well characterised and 
reproducible dosage forms (Levina and Rajabi-
Siahboomi 2004). 
Controlled release systems can be influenced by 
physiological conditions such as motility, ions, pH and 
enzymes (Abrahamsson et al. 2004, Singh et al. 1968). 
Hydrophillic matrix systems are among the most 
commonly used means for oral controlled drug delivery 
as they can reproduce a desirable drug profile and are 
cost effective (Prajapati and Patel  2010, The Dow 
Chemical Company 2000). The primary mechanism of 
drug release from hydrophilic matrices occurs when the 
polymer swells on contact with the aqueous medium to 
form a gel layer on the surface of the system. The drug 
then releases by dissolution, diffusion and/or erosion 
(Colombo 1993, Ishikawa et al.  2000, Siepmann and 
Peppas 2001a, Tiwari and Rajabi-Siahboomi 2008). 
Advantages of oral controlled release formulations  
This type of drug delivery has been at the centre of 
research due to its many benefits over conventional 
dosage forms, some of which are as follows: 
•  The frequency of dosing is reduced due to drug being 
released over a longer period of time unlike 
conventional tablets (Kojima et al.  2008). This is 
extremely valuable for patients with chronic illnesses 
which require the plasma concentrations of a drug to 
be within its therapeutic range to avoid breakthrough 
symptoms, for example, overnight management of 
pain in terminally ill patients (Aulton 2008). 
•  The reduction or avoidance of side effects due to 
high plasma drug concentrations or ‘dose dumping’ 
(Maderuelo et al. 2011). 
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•  Improvement in patient compliance due to reduced 
dosing (Maderuelo et al. 2011). 
•  Better control of therapeutic drug concentration; 
•  Cost effective manufacturing (Maderuelo et al. 2011) 
as the amount of tablets needed per patient would be 
reduced compared to its conventional form. 
Disadvantages of oral controlled release formulations 
Oral controlled release formulations like other 
formulations have several disadvantages. These include 
(DiMatteo and DiNicola 1982, Jayanthi et al.  2011, 
Kayser et al. 2005, Sansom 1999): 
•  Development costs: Expensive specialised equipment 
and inert ingredients may be required for some 
controlled release formulations. 
•  Release rate: The drug release rate can be altered by 
food and gastric transit time; as a result differences 
may arise in the release rate between doses. 
•  Can not crush or chew products: Controlled release 
products should not be crushed or chewed as it can 
lead to loss of the ‘slow release’ characteristics as 
well as toxicity. 
The effect of  drug properties in developing oral 
controlled release  
Alongside the benefits and disadvantaged, sustained 
release dosage forms have also posed many challenges 
for pharmaceutical technologists (Khan 1996). In order 
for drug release to be manipulated and for the resulting 
product to possess the above mentioned characteristics 
there are many factors that need to be taken into 
consideration when designing such formulations. Some 
of these are as follows: 
 
•  Different drug solubility’s need to be considered 
(Sudha  et al.  2010) as highly soluble drugs will 
dissolve immediately after administration (Siahi et al. 
2005). Reduced drug solubility increases the 
tendency of the tablet to erode due to particle 
displacement (Bettini et al. 2001). 
•  The drug should have a short half-life (Aulton 2008). 
If a drug has a long half-life then there is a risk of 
accumulation as it will be eliminated at a slower rate 
compared to its absorption (Kim 2000). 
•  A drug that is tested in-vitro  needs to be able to 
provide similar release characteristics once 
administered and is under pathophysiological or in-
vivo conditions (Khan 1996, Diakidoua et al. 2009). 
A direct correlation of in-vitro  data with in-vivo 
release is not possible without thorough and careful 
analysis (Khan 1996). For example, there is a 
difference in the availability of water in different 
parts of the gastrointestinal tract and such factors 
need to be considered when designing tablets for 
extended release (Khan 1996, Kojima et al. 2008).  
•  The dissolution characteristics should allow for drug 
to be released in a controlled manner, highlighting 
the importance for the correct selection of polymers 
according to their physical, mechanical and 
pharmacokinetic properties (Kim 2000).  
 
Different types of sustained release systems 
There are several types of sustained release systems that 
are designed and categorised according to the 
mechanism they employ. These include diffusion 
controlled, dissolution controlled, erosion controlled, ion 
exchange controlled and transport control also known as 
osmotic pump systems (Aulton 2008). 
Matrix systems 
Diffusion controlled systems also known as matrix 
systems are very popular for sustained release 
formulations (Colombo et al. 2000). The can be divided 
up into different types of mechanisms by which they 
prolong drug release, these includes reservoir matrix 
systems, monolithic matrix systems and osmotic pump 
systems. 
Reservoir matrix systems 
This system involves a membrane which controls the 
release of drugs from the matrix system. The drug will 
eventually diffuse through the membrane and its release 
is kept constant by the diffusion distance that the drug 
particles have to cover (Fig. 1). 
 
 
Fig. 1. Schematic representation of Reservoir matrix systems (The figure is adopted from Dash and Cudworth 1998).  
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Osmotic pump systems 
Osmotic systems operate on osmotic pressure. They 
contain a core tablet that is surrounded by a 
semipermeable membrane coating which has an orifice. 
The core tablet has two layers to it, one containing the 
active ingredient/drug known as the active layer and the 
second containing the osmotic agent which is also 
known as the push layer (Allen 2005). Water enters the 
tablet through the semipermeable membrane causing the 
drug to dissolve and suspend. The increase in osmotic 
pressure causes the dissolved/suspended drug to be 
pumped out of the delivery orifice (Allen 2005). The rate 
of drug delivery can be changed by altering the size of 
the delivery orifice and the thickness of the 
semipermeable membrane (Allen 2005). 
Monolithic matrix systems 
These systems involve drug to be encapsulated or 
dispersed in a matrix (Kim 2000). These systems can be 
employed by forming hydrophobic matrices (Varshosaz 
et al.  2007) and/or hydrophilic matrices to allow for 
control or prediction of drug release (Colombo 1993, 
Nerurker  et al.  2005, Thawatchai 2008). They can be 
divided into soluble/hydrophilic matrix systems which 
swell on hydration and dissolve to release drug and 
insoluble/hydrophobic matrix systems which release 
drug after being dissolved by a solvent (Fig. 2). 
Hydrophobic matrix systems are formulated by waxes 
mainly and can be suitable for drugs which have a high 
solubility (Tiwari et al. 2003). Wax based matrices have 
been investigated to ascertain the factors that would 
affect the release of drug (Sudha et al.  2010). Drug 
release has been successfully modulated in hydrophobic 
matrices however, in a study conducted by Sudha and 
co-workers (2010) it was concluded that matrices which 
are based on waxes can modify release rate by increasing 
the amount of drug or wax concentration, as well as 
incorporating hydrophilic polymers which would 
enhance the release. Even though the hydrophobic 
matrix was able to modulate drug release, the processes 
that had to be carried out such as hot fusion and thermal 
treatment highlighted the length of the process that 
would be required to form such tablets. This can 
potentially be a deterrent for manufacturing companies 
who would prefer a more economical method of 
producing sustained release formulations.  
Hydrophilic matrix systems tend to be more popular in 
tablet manufacture for controlled release drug delivery 
systems due to their low manufacturing cost (Tiwari 
2003). On contact with water a hydrophilic matrix 
increases in size due to the entry of the solvent. This then 
allows the polymer to swell up forming a barrier to drug 
release. The drug particles would then move through this 
gel layer via diffusion or erosion of the gel eventually 
allowing drug to be released (Maderuelo et al.  2011). 
There has been a lot of research into the mechanisms of 
drug release from hydrophilic matrices and the critical 
factors that influence the release rate (Colombo et al. 
2000, Maggi et al. 2002, Siahi 2005, Conti et al. 2007, 
Thawatchai 2008, Maderuelo et al. 2011, Siahi-Shadbad 
et al. 2011).  
These swellable matrices have more than one ‘front’ as a 
part of its release mechanism (Colombo et al.  2000). 
This has been shown in Fig. 3. 
 
 
 
Fig. 2. Schematic representation of drug release from different types of matrix tablets. 
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Fig. 3. Different front within a matrix tablet containing colouring agent to distinguish different swelling fronts. 
 
 
Table 1. Examples of a few polymers used in formulation of controlled release dosage forms 
Hydrophilic Polymers  Methylcellulose, Hydroxypropylmethylcellulose (HPMC), Hydroxypropylcellulose (HPC), 
Hydroxyethylcellulose (HEC), Ethylhydroxyethylcellulose (E-HEC), Sodium-carboxymethylcellulose 
(Na-CMC) 
Non-cellulosic  Sodium alginate, Xanthan gum, Carrageenan, Chitosan, Guar gum, Pectin, Polyethylene oxide 
Hydrophobic Polymers  Ethylcellulose, Hypromellose acetate succinate, cellulose acetate, cellulose acetate propionate 
 
The area of dissolved drug and un-dissolved drug are 
separated by two types of “fronts” from the swollen gel 
region. They have a diffusion front which is located in 
between the swelling and erosion front (Colombo et al. 
2000, Maderuelo et al. 2011). Drug release can occur by 
many mechanisms such as erosion, diffusion, polymer 
relaxation or a combination. Modulation of drug release 
from geomatrix multi-layered tablets was proposed by 
Conti and Maggi (1996) and they found that a swellable 
barrier  around an active core provides greater 
modulation for soluble drugs.  
Polymers in sustained release formulations  
Polymers are chains of covalently bound monomers. 
They are used throughout the pharmaceutical industry 
and in relation to oral drug delivery systems they are 
used as carriers for the drug (Colombo et al.  2000). 
Polymers are used as a backbone in conventional and 
controlled release formulations (Kim 2000). For 
sustained release formulations the polymers need to have 
certain characteristics to control and maintain the rigidity 
of the matrix over a prolonged period (Kim 2000). There 
are a large number of polymers that are used in sustained 
release drug delivery (Table 1) (Maderuelo et al. 2011): 
For the purpose of this study, the polymers that will be 
discussed are hydroxypropyl-  methylcellulose, sodium 
carboxymethylcellulose and sodium alginate. 
Hydroxypropylmethyl cellulose (HPMC) 
HPMC is a non-ionic derivative of cellulose ether 
(Kamel et al. 2008), it is stable over pH range 3.0-11 
(Lee et al. 2005). Hydroxypropylmethlcellulose (HPMC) 
is a semi-synthetic polymer (Colombo 1993, Ferrero-
Rodriquez et al. 2000, Siepmann and Peppas 2001a). It 
is used as first choice for the formulation of hydrophilic 
matrix systems as it provides a robust mechanism for 
controlled release of drugs and choice of viscosity 
grades. Its non ionic nature minimises interaction 
problems when used in acidic, basic or electrolytic 
systems and provides reproducible release profiles. It is 
also cost effective (Bettini et al. 1995, Colorcon 2005, 
Conti et al. 2007). Matrices containing HPMC are not 
affected by the pH of fluid (Conti et al.  2007). 
Nokhodchi et al. (1995) found that the best grades to use 
for sustained release formulations are K4M and K100M 
due to their high tensile strength. When hydrated the 
polymer chains disentangle from the matrix (Kamel et 
al. 2008). HPMC matrix systems are classed as swelling 
controlled systems and are controlled by the rate of 
penetration of media and erosion of the matrix (Tahara et 
al. 1995). In hydrophilic polymers the rate of swelling 
determines the presence of different fronts within the 
matrix and when the movement of these front is 
synchronised then the drug release rate is constant 
(Colombo 1993).  
HPMC is a mixture of alkyl hydroxyalkyl cellulose ether 
containing methoxyl and hydroxypropyl groups (Fig. 4). 
The rate of hydration of HPMC depends on the nature of 
the substituent’s that form the polymer e.g. molecular 
structure, degree of substitution (Alderman 1984). The 
percentage of methoxyl and hydroxypropoxyl for 
different chemistry of HPMC are listed in Table 2. 
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Fig. 4. The structure of hydroxypropyl methylcellulose (taken from The Dow Chemical Company 2000). 
 
There are also different viscosity grades of HPMC 
available. And an example is shown in Table 2 for K 
chemistry. The initial letter identifies the chemistry of 
the type of cellulose ether; ‘K’ identifies different 
HPMC products. METHOCEL K is one of the most 
widely used for controlled release drug formulations 
(The Dow Chemical Company 2000). The number that 
follows the initial letter identifies the viscosity grade in 
millipascal-seconds (m.Pa.s) for the product measured in 
2% aqueous solution at 20
oC. Millipascal-second is 
equivalent to centipoises (cPs). The letter followed by 
the number identifies the viscosity. The letter ‘M’ 
suggests  the value is multiplied by 1000 and the 
abbreviation ‘LV’ represents special low viscosity 
products. The abbreviation ‘CR’ denotes controlled 
release grades (The Dow Chemical Company 2000). 
All these have been summarized in Fig. 5. Many studies 
have demonstrated the drug release profile from a 
hydrophilic matrix tablet is influenced by the viscosity of 
the gel layer formed by HPMC (Alderman 1984, 
Colombo 1993, Lee 1985).  
 
Table 2. Various grades of HPMC (taken from The Dow Chemical Company 2000) 
HPMC type*  Methoxy (%)  Hydroxypropoxy  other names 
K  19-24  4-12  Hypromelose 2208 
E  28-30  7-12  Hypromelose 2910 
F  27-30  4-7.5  Hypromelose 2906 
*Different viscosity grades are available on the market (e.g. for K series 
HPMC K100LV, HPMC K4M, HPMC K15M and HPMCK100M). 
 
 
 
Fig. 5. Summary of nomenclature for METHOCEL K cellulose ether (adapted from The Dow Chemical Company 2000). 
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Compared to other swellable polymers used to prolong 
drug release, HPMC is said to have been the most widely 
used due to its rapid hydration, good compression and 
gelling characteristics. In addition it has very low 
toxicity and is generally widely available for use 
(Alderman 1984, Colombo 1993, Lee 1985, Wan et al. 
1995). Hence it has been a material of great importance 
when used as a carrier in drug release systems.  
Mechanism of drug release 
Alderman (1984) describes a gel layer being formed 
around a tablet (Fig. 6); this is because when hydrophilic 
matrices are immersed in aqueous media i.e. Gastro-
intestinal fluids, the polymer hydrates and swells 
resulting in an increase in size. After some  time the 
matrix dissolves or erodes allowing drug release (Lee 
1980, Peppas et al.  1980). The soluble portion of the 
drug is released by the process of diffusion through the 
gel layer while the insoluble portion is released through 
tablet erosion (Johnson et al. 1993, Lindner and Lippold 
1995, Skoug et al. 1993, The Dow Chemical Company 
2000). Studies have shown that drug release from 
swellable hydrophilic matrices is dependent on the 
thickness of the hydrated layer that is formed during 
polymer hydration.  The degree of swelling determines 
the rate of drug release; the thicker the gel layer, the 
slower the rate of drug release (Johnson et al.  1993, 
Skoug et al. 1993, Sujja-areevath et al. 1998). 
Physiological factors of the gastro-intestinal (GI) tract 
can  affect the release of drugs. This includes pH, GI 
transit time, intestinal motility, and GI contents, for 
example fed and fasted states (Charman et al.  1997, 
Grundy and Foster 1996, Streubel et al. 2000). 
Factors affecting drug release 
Effect of viscosity  
Viscosity is defined as a measure of resistance of a fluid 
to flow. In relation to polymer solutions, viscosity is 
dependent upon the molecular weight of the polymer 
(Indian Academy of Sciences 2010). Viscosity of 
polymer solutions is the result of polymer chain 
hydration through hydrogen bonding of oxygen atoms in 
ether linkages, causing them to extend and form 
relatively open random coils. The hydrated coils 
continue to hydrogen bond to additional water molecules 
causing entrapment within the coils (The Dow Chemical 
Company 2000). Viscosity can therefore affect the extent 
of drug release from hydrophilic matrices. 
 
 
Fig. 6. Mechanism of drug release from a hydrophilic matrix tablet (adapted from The Dow Chemical Company 2000). 
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Rahman  et al.  (2011) explored viscosity grades of 
HPMC matrix systems as oral controlled release drug 
delivery systems using a non-steroidal anti-inflammatory 
drug, diclofenac sodium (Fig. 7). All viscosities of 
HPMC were used which included K100M, K15M, K4M 
and K100LV. The results demonstrated significant 
differences among the drug release profile from different 
matrices. The drug release from the higher viscosity 
grade K100M was slower compared to the lower 
viscosity grade K100LV (Fig. 7). As the release of 
diclofenac sodium from the HPMC K100M matrix was 
prolonged, it was able to avoid gastro-intestinal adverse 
effects. The release rate was considerably dependent on 
the viscosity grade of HPMC as it showed a statistically 
significant increase in drug release with low viscosity 
HPMC (P<0.05). 
 
 
 
Fig. 7. A zero order plot showing the release kinetics of 
diclofenac sodium matrix tablets (taken from Rahman et al. 
2011). 
 
 
It can be concluded the higher viscosity grade of HPMC 
(K100M) can strengthen the gel layer and retard the 
penetration of water into the dry matrix core. This results 
in decreased release of water soluble and water insoluble 
drugs (Alderman 1984). 
Effect of pH  
The gastro-intestinal (GI) pH is one of the major 
properties of GI fluids and varies greatly along the 
digestive tract under fed and fasted conditions (Charman 
et al.  1997). It has an influence on the dynamics of 
HPMC hydrophilic matrix systems and can affect the gel 
layer formation (Tritt-Goc et al. 2005). Due to its non 
ionic nature, the viscosities of HPMC polymers are 
generally stable over a wide pH range of 3-11. This 
means if drug solubility is pH dependent, the drug 
release from the HPMC matrix will also be pH 
dependent (Asare-Addo  et al.  2011). The transit time 
explains the time taken for food to move through the 
different segments of the GI tract (Table 3). 
 
Table 3. Transit time and pH values used to mimic the GI tract 
(taken from Asare-Addo et al. 2011) 
GI tract segment  pH value  Transit time (min) 
Stomach  1.2  60 
Stomach  2.2  60 
Duodenum  5.8  10 
Jejunum  6.8  120 
Proximal ileum  7.2  30 
Distal ileum  7.5  30 
 
Asare-Addo et al. 2011 explored the effects of pH on 
theophylline release from HPMC matrix tablets. The 
results indicated higher drug release from low viscosity 
HPMC in acidic pH 1.2 which continued to decrease as 
the pH increased to alkaline (Fig. 8). 
 
 
 
Fig. 8. A graph showing the drug release contribution from 
matrices made from different HPMC grades in pH media (taken 
from Asare-Addo et al. 2011). 
 
 
In addition a study carried out by Tritt-Goc  and 
Kowalczuk  (2005) investigated the effects of pH and 
molecular mass on the hydration of HPMC. The study 
used magnetic resonance imaging (MRI) to generate 
images of HPMC swelling at different times. Fig. 9 
shows the images of HPMC grades in acidic conditions. 
It shows the growth of the gel layer with time hence an 
increase in the diameter of the polymer and a reduction 
of the dry core. This study therefore supports the fact 
that drug release is higher in acidic conditions (i.e. 
stomach) for low viscosity HPMC as the gel layer is 
thinner thus allowing penetration of water. 
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Fig. 9. Atypical two-dimensional MR images of swollen HPMC tablets after different times of swelling (pH = 2) (taken from Tritt-Goc and 
Kowalczuk 2005). 
 
Effect of ionic strength 
Ionic strength is also a major property of GI fluids and 
can affect the rate of drug release from HPMC matrices 
(Asare-Addo et al. 2011, Charman et al. 1997). In fasted 
conditions the ionic strength is approximately 0.11 M, 
however variability can be expected in the fed state 
depending on food composition. The ionic concentration 
is maintained at a constant level in the jejunum due to 
water and ion secretion and the remainder of the 
intestinal tract is estimated to be approximately 0.14 M 
in fasted conditions (Asare-Addo et al. 2011, Bonferoni 
et al.  1995, Lindhal et al.  1997). Generally the ionic 
concentration strength of the GI tract under both fed and 
fasted states is a range of 0-0.4 M (Johnson et al. 1993). 
A study by Asare-Addo  et al.  (2011) investigated the 
effects of ionic strength on theophylline release from 
HPMC matrix tablets. It was observed that as the ionic 
strength increased, the amount of theophylline released 
also increased. The ionic concentration strengths 
mimicked the potential effects of food, 0.2 M: low 
content of food and 0.4 M: high content of food. The 
results indicated ionic concentration had a significant 
effect on the release pattern of K100LV matrices (Fig. 
10). K100M matrices had the lowest drug release rate 
and produced a strong gel layer suggesting high viscosity 
grades are the best candidates for producing controlled 
release profiles that are less affected by food. 
Sodium carboxymethyl cellulose (NaCMC) 
This is a polyelectrolyte ionic cellulose derivative which 
is sensitive to changes in pH (Rimmer 2005). On 
hydration, polymer chains of NaCMC sell and untangle 
forming a viscous gel layer on the surface (Saeedi et al. 
2009). The influence of NaCMC on drug release has 
been studied by many people (Bonferoni et al.  1995, 
Conti et al. 2007, Mohammadi et al. 2009, Saeedi et al. 
2009). Erosion of the gel has been found to be one of 
main mechanisms by which this polymer releases drug 
(Bonferoni et al. 1995).  
 
 
 
Fig. 10.  Graph showing the drug release contribution from 
matrices made from different HPMC grades in ionic strength of 
0.2 M and 0.4 M (taken from Asare-Addo et al. 2011).  
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Alginate 
Alginates are found in brown marine algae and are 
natural polymers that are used in various areas such as 
the food industry used them as thickeners and in the 
pharmaceutical industry they are used in tablet 
manufacture as binders and tablet disintegration. 
Alginates have been used controlled release formulations 
due its ability to form a gel upon hydration. Liew and co-
workers (2006) evaluated sodium alginate (NaAlg) as a 
drug release modifier in matrix tablets by using 17 
different grades with differing particle size, viscosities 
and chemical compositions. They concluded that sodium 
alginate has a unique feature which enables gel-
formation in acidic media as well as neutral media and 
these features need to be utilised when designing a 
controlled release formulation. A study conducted by 
Giunchedi and co-workers (2000) focused on evaluating 
alginate compressed matrices as prolonged release 
systems. They found that sodium alginate (NaAlg) can 
be used successfully as a drug release modifier in matrix 
tablets alongside another polymer. In all studies 
mentioned, the contribution of a cation (mainly calcium) 
has also given varying results which suggests that this 
interaction is a vital determinant of drug release. 
Effect of cations 
Polyvalent cations such as Al
3+,  Ca
2+, Zn
2+  and Mg
2+ 
have been used to form cross-links with alginate 
molecules (Al-Musa et al. 1999, Nokhodchi and Tailor 
2004). The presence of cations within a matrix 
containing alginate allows for bridges to be formed 
between the anionic polymer chains (Braccini 1999, 
Ching  et al.  2008) forming a network known as a 
hydrogel. The link can also be described as the ‘egg-box 
model’ (Fig. 11), describing the bonding between 
alginate and a divalent cations (such as Ca
2+ and Zn
2+) in 
a two dimensional manner (Grant et al. 1973).  
 
 
Fig. 11.  Egg box model of calcium and alginate in a two 
dimesional planar manner network (Al-Musa et al. 1999). 
 
 
Aluminium ions on the other hand (Fig. 12) would have 
a different interaction with alginate molecules due them 
having an extra valence available for bonding (Al-Musa 
et al. 1999). 
 
 
Fig. 12. Diagrammatic representation of possible cross-linking of Aluminium ions with alginate (Al-Musa et al. 1999).  
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This allows cross-linking to a greater extent than 
divalent cations as aluminium ions have an extra positive 
charge per unit of surface (Mohammadi 2009). The 
formation of hydrogels modulates drug release from 
sustained release formulations and has been used in 
microspheres, beads and film coating (Chan et al. 2006, 
Lee  et al.  2005). They are also used extensively in 
matrix tablets to preserve the matrix structure and avoid 
early disintegration of the matrix (Ching et al.  2007). 
However, the concentration of cation plays an important 
role in how quickly or slowly drug is released 
(Nokhodchi and Tailor 2004, Ching et al.  2007, 
Mohammadi et al. 2009). 
 
Kinetics of drug release 
The release behaviour of drugs from hydrophilic 
matrices can be mathematically expressed by the 
following equation which is known as Higuchi equation: 
 
M = k.t
0.5       
 
Where k is a constant and M is the amount of drug 
released at time t. 
Higuchi’s equation initially was valid only for planar 
matrix systems, and later it was modified to consider 
different geometrical shapes and matrix characteristics 
including porous structures (Lapidus and Lordi 1966, 
1968, Higuchi 1963, Desai et al. 1965, 1966). It should 
be kept in mind that the classical equation was derived 
under pseudo-steady state assumptions and cannot be 
applied to real controlled release systems (Peppas 1984). 
The final equation shows that if a system is 
predominantly diffusion-controlled, then it is expected 
that a plot of the drug release against square root of time 
will result in a straight line.  
The mechanism of drug release from hydrophilic matrix 
tablets after ingestion is complex but it is based on 
diffusion of the drug through, and erosion of, the outer 
hydrated polymer on the surface of the matrix. In the 
case of a highly soluble drug, this phenomenon may lead 
to an initial burst release due to the presence of the drug 
on the surface of the matrix tablet. The gel layer 
(rubbery state) grows with time as more water permeates 
into the core of the matrix, thereby increasing the 
thickness of the gel layer and providing a diffusion 
barrier to drug release (Rajabi-Siahboomi et al. 1996). 
The gel layer thickness behaviour is crucial in describing 
the release kinetics of swellable matrices. 
Simultaneously, as the outer layer becomes fully 
hydrated, the polymer chains become completely relaxed 
and can no longer maintain the integrity of the gel layer, 
thereby leading to disentanglement and erosion 
(dissolution) of the surface of the matrix. Water 
continues to penetrate towards the core of the tablet, 
through the gel layer, until it has been completely eroded 
(Lee and Peppas 1987, Narasimhan and Peppas 1997). 
At the point of disentanglement an abrupt change occurs 
in the rheological properties of the gel layer (Caramella 
et al. 1989). This indicates that the interactions between 
polymer-polymer and polymer-solvent are important in 
controlling the gel network structure and erosion. In 
addition, the strength of gel can play major role in 
controlling the drug release from this type of matrices.  
A large number of mathematical models have been 
developed to describe drug release profiles from 
matrices (Siepmann and Siepmann 2008, Siepmann and 
Peppas 2000, 2001a,b, Siepmann et al. 1999, 2002). The 
simple and more widely used model is the one derived 
by Korsmeyer et al. (Siepmann et al. 1999) and is as 
follows: 
 
Mt /Mα= k t 
n        
 
where Mt /Mα is the fraction of drug release, k is the 
diffusion rate constant, t is the release time and n is the 
release exponent indicative of the mechanism of drug 
release. 
It is clear from equations 6 and 7 that when the exponent 
n  takes a value of 1.0, the drug release rate is 
independent of time. This case corresponds to zero-order 
release kinetics (also termed as case II transport). Here, 
the polymer relaxation and erosion (Bajwa et al. 2006) 
are the rate-controlling steps. When n  = 0.5, Fickian 
diffusion is the rate-controlling step (case I transport). 
Values of n between 0.5 and 1 indicate the contribution 
of both the diffusion process as well as polymer 
relaxation in controlling the release kinetics (non-
Fickian, anomalous or first-order release). It should be 
noted that the two extreme values of n = 0.5 and 1 are 
only valid for slab geometry. For cylindrical tablets, 
these values range from 0.45 < n  < 0.89 for Fickian, 
anomalous or case II transport respectively (Siepmann 
and Peppas 2001b). 
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